Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Long-Term Follow-Up of Thalassemia Major Patients with Hepatitis C Virus Treated with Sofosbuvir and Daclatasvir: A Cohort Study
Archives of Medical Research
November 2022
Safarnezhad Tameshkel F.
Safety and Efficacy of Direct Acting Antivirals for Hepatitis C Virus Infection in Thalassemic Patients and Its Effect on Transfusion Requirements
Egyptian Journal of Hospital Medicine
April 2022
Naguib G.G.
Open Access
Diagnostic approach to elucidate the efficacy and side effects of direct-acting antivirals in HCV infected patients
Journal of Infection in Developing Countries
October 2021
Younas S.
Open Access
Codon usage of human hepatitis C virus clearance genes in relation to its expression
Journal of Cellular Biochemistry
1 January 2020
Singh P.
Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort study
Caspian Journal of Internal Medicine
2020
Sharafi H.
The Course of Hepatitis C Infection and Response to Anti-viral Therapy in Patients with Thalassemia major and Hepatitis C Infection: A longitudinal, prospective study
Mediterranean Journal of Hematology and Infectious Diseases
2019
Kamal S.
Open Access
A facile PCR-RFLP method for genotyping of ITPA rs1127354 and rs7270101 polymorphisms
Journal of Clinical Laboratory Analysis
September 2018
Alavian S.E.
Open Access
Psychiatric side effects of pegylated interferon-α and ribavirin therapy in iranian patients with chronic hepatitis c: A meta-analysis
Experimental and Therapeutic Medicine
August 2018
Davoodi L.
Open Access
The effectiveness of sofosbuvir and daclatasvir in the treatment of hepatitis C in thalassaemia major patients and their effect on haematological factors
Indian Journal of Medical Microbiology
April-June 2018
Zamani F.
Open Access
Efficacy and safety of generic sofosbuvir/ledipasvir fixed-dose combination in Iranian patients with chronic hepatitis C virus infection
Hepatitis Monthly
June 2017
Sharafi H.
Open Access
Assessment of hepatitis C virus RNA in peripheral blood mononuclear cells as a predictor of response to pegylated-interferon and ribavirin: A cohort study
Iranian Red Crescent Medical Journal
May 2017
Miri S.M.
Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation
Hepatology Research
1 October 2016
Shinoda M.
Open Access
Next steps toward eradication of hepatitis C in the era of direct acting antivirals
Hepatitis Monthly
18 April 2016
Hesamizadeh K.
Open Access
Predictors of pegylated interferon alpha and ribavirin efficacy and long-term assessment of relapse in patients with chronic hepatitis c: A one-center experience from China
Hepatitis Monthly
1 June 2015
Wu Q.
Open Access